Overview Multiple Ascending Dose Study of SPC4955 in Healthy Subjects Status: Completed Trial end date: 2011-11-01 Target enrollment: Participant gender: Summary The purpose of this study is to study safety and tolerability of SPC4955 in healthy subjects. Phase: Phase 1 Details Lead Sponsor: Santaris Pharma A/S